Sign Out
Clear, colourless liquid. A few white to translucent particles may be present.
1 mL of concentrate for solution for infusion contains 1000 mcg tagraxofusp. Each vial contains 1000 mcg of tagraxofusp.
Tagraxofusp is a diphtheria toxin-interleukin-3 (IL-3) fusion protein produced by recombinant DNA technology in Escherichia coli.
Excipient with known effect: Each vial contains 50 mg of sorbitol.
Excipients/Inactive Ingredients: Tromethamine base (Tris) buffer, Sodium chloride, Sorbitol, Hydrochloric acid, Sodium hydroxide, Water for injections.
